The first-line use of electroconvulsive therapy in major affective disorders

Journal of ECT

Volumn 20, Issue 2, 2004, Pages 112-117

  Maletzky, Barry M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Affective disorders; Catatonia; Depression; Electroconvulsive therapy; First line use; Primary use; Refractory depression

Indexed keywords

ADULT; AGED; AMNESIA; ANAMNESIS; ARTICLE; CATATONIA; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; HEADACHE; HUMAN; MAINTENANCE THERAPY; MAJOR AFFECTIVE DISORDER; MALE; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PREGNANCY; RATING SCALE; RETROSPECTIVE STUDY; SEIZURE THRESHOLD; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; CATATONIA; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 2942585218     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200406000-00007     Document Type: Article

References (30)

1. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153:985-992.
2. Thase ME, Rush AJ. Treatment-resistant depression. In: Bloom F, Kupfer D, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995:1081-1098.
3. Fava M, Davidson RG. Definition and epidemiology of treatmentresistant depression. Psychiatr Clin North Am. 1996;19:179-200.
4. Flint AJ, Rifat SL. Two-year outcome of psychotic depression in late life. Am J Psychiatry. 1998;155:178-183.
5. Trivedi MH, Kleiber BA. Algorithm for the treatment of chronic depression. J Clin Psychiatry. 2001;62(suppl 6):22-29.
6. Osser DN. The Harvard Psychopharmacology Algorithm Project. Psychiatr Ann. 1999;29:270-284.
7. Suppes T, Dennehy EB, Swann AC, et al. Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry. 2002;63:288-299.
8. Fink M. Convulsive Therapy: Theory and Practice. New York: Raven Press; 1979;56.
9. Sackeim HA. The use of electroconvulsive therapy in late-life depression. In: Salzman C., ed. Geriatric Psychopharmacology. 3rd ed. Baltimore, MD: Williams & Wilkins; 1998:262-309.
10. Weiner RD, Coffey CE, Krystal AD. Electroconvulsive therapy in the medical and neurologic patient In: Stoudemire A, Fogel BS, Grenberg D, eds. Psychiatric Care of the Medical Patient. 2nd ed. New York: Oxford University Press; 2000:419-428.
11. Petrides G, Fink M, Husain MM. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17:244-253.
12. Swartz CM, Morrow V, Surles L, et al. Long-term outcome after ECT for catatonic depression. J ECT. 2001;17:180-183.
13. Nobler MS, Sackeim HA, Moeller JR, et al. Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. Convuls Ther. 1997;13:208-221.
14. Segman RH, Shapira B, Gorfine M, et al. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology (Berl). 1995;119:440-448.
15. Abrams R. Electroconvulsive Therapy. 2nd ed. New York: Oxford University Press; 1992.
16. Coffey CE. ed. The Clinical Science of Electroconvulsive Therapy. Washington, DC: American Psychiatric Press; 1993.
17. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recornmendations for Treatment, Training, and Privileging. 2nd ed. Washington, DC: American Psychiatric Press; 2001.
18. Schatzberg AF, Cole JO, DeBattista C. Manual of Clinical Psychopharmacology. 4th ed. Washington, DC: American Psychiatric Publishing; 2003:72.
19. Fink M, Taylor MA. Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge, UK: Cambridge University Press; 2003.
20. Maletzky BM. Multiple-Monitored Electroconvulsive Therapy. Boca Raton, FL: CRC Press; 1981.
21. Nelson JC. Managing treatment-resistant major depression. J Clin Psychiatry. 2003;64(suppl 1):5-12.
22. Shelton RC. The use of antidepressants in novel combination therapies. J Clin Psychiatry. 2003;64(suppl 2):14-18.
23. Olfson M, Marcus S, Sackeim HA, et al. Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry. 1998;155:22-29.
24. Thase ME. Effectiveness of antidepressants: comparative remission rates. J Clin Psychiatry. 2003;64(suppl 2):3-7.
25. Thase ME. Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry. 2003;64(suppl 13):18-25.
26. Sackeim H, Prudic J, Demavend DP, et al. A prospective, randomized double blind comparison between bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57:425-434.
27. Abrams R. Electroconvulsive Therapy. 3rd ed. New York: Oxford University Press; 1997.
28. Lapid MI, Rummans TA, Poole KL, et al. Decisional capacity of severely depressed patients requiring electroconvulsive therapy. J ECT. 2003;19:67-72.
29. Palmer B, Nayak G, Dunn L, et al. Treatment-related decision-making capacity in middle-aged and older patients with psychosis. Am J Geriatr Psychiatry. 2002;10:207-211.
30. Grisso T, Applebaum P. Assessing Competence to Consent to Treatment: A Guidefor Physicians and Other Health Professionals. New York: Oxford University Press; 1998.